| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Robin James Scott Cridland |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 2.25p |
| Change Today | -0.050p |
| % Change | -2.17 % |
| 52 Week High | 4.80 |
| 52 Week Low | 1.94 |
| Volume | 588,482 |
| Shares Issued | 803.36m |
| Market Cap | £18.08m |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:16 | 217,992 @ 2.34p |
| 14:25 | 50,000 @ 2.22p |
| 12:49 | 3,229 @ 2.22p |
| 11:56 | 217,218 @ 2.30p |
| 08:20 | 43 @ 2.40p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research